Funding round to fuel product development, talent recruitment and expansion into additional market segments NEW YORK, April 22, 2020-- H1, a provider of data driven solutions for the healthcare industry, announced today the completion of its first institutional funding round. Menlo Ventures led the $12.9 million Series A, joined by Novartis dRx, Y Combinator, Baron Davis Enterprises, ClearPoint Investment Partners, Jeff Hammerbacher, Liquid 2 Ventures, and Underscore VC. Greg Yap, partner at Menlo Ventures, will join H1's board of directors.